Trial Profile
Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Suramin sodium (Primary) ; Hydrocortisone
- Indications Adrenal cancer
- Focus Therapeutic Use
- 26 Sep 2005 New trial record.